A COST-EFFECTIVENESS MODEL OF BAZEDOXIFENE VS. RALOXIFENE FOR THE PREVENTION OF FRACTURES IN SPANISH POSTMENOPAUSAL WOMEN

被引：0
|
作者：
Darba, Josep [1 ]
Perez-Alvarez, Nuria [2 ]
Kaskens, Lisette [2 ]
Racketa, Jill [3 ]
Rejas, Javier [4 ]
机构：
[1] Univ Barcelona, E-08007 Barcelona, Spain
[2] BCN Hlth Econ & Outcomes Res, Barcelona, Spain
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Inc, Hlth Econ & Outcomes Res Dept, Madrid, Spain
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 257
页数：2
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF PRIMARY PREVENTION FOR OSTEOPOROTIC HIP FRACTURES IN ELDERLY WOMEN
    Comas, M.
    Posso, M.
    Louro, J.
    Espallargues, M.
    Tebe, C.
    Domingo, L.
    Castells, X.
    VALUE IN HEALTH, 2018, 21 : S295 - S295
  • [32] Cost-effectiveness of teriparatide in the prevention of osteoporotic fractures in Australian men and women
    Lees, M
    Graham-Clarke, P
    Davey, P
    Thiebaud, D
    Price, N
    Grainger, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S12 - S13
  • [33] INDIRECT COMPARISON OF BAZEDOXIFENE VS. ORAL BISPHOSPHONATES FOR THE PREVENTION OF NONVERTEBRAL FRACTURES IN A HIGH-RISK POSTMENOPAUSAL OSTEOPOROSIS POPULATION
    Ellis, Alexandra
    Jansen, Jeroen
    Luo, Xuemei
    Cappelleri, Joseph C.
    Chines, Arkadi
    Sutradhar, Santosh
    Reginster, Jean-Yves
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S64 - S65
  • [34] The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women
    Papadimitropoulos, EA
    Blackhouse, G
    Goeree, R
    Coyte, PC
    Josse, RG
    Adachi, JD
    Greenwood, CE
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S84 - S85
  • [35] The cost-effectiveness of calcium and Vitamin D or hormone replacement therapy in the prevention of osteoporotic fractures in Canadian postmenopausal women.
    Papadimitropoulos, E.
    Goeree, R.
    Blackhouse, G.
    Coyte, P. C.
    Josse, R. G.
    Adachi, J. D.
    Greenwood, C. E.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S279 - S279
  • [36] Strategies for the prevention of osteoporosis in postmenopausal women with hormone therapy and serms: Cost-effectiveness issues
    Torgerson, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S99 - S99
  • [37] The cost-effectiveness of raloxifene compared with no drug therapy for the prevention of osteoporotic fractures when HRT is inappropriate: The case of Australia
    Davey, P
    Lees, M
    Graham-Clarke, P
    VALUE IN HEALTH, 2002, 5 (06) : 455 - 456
  • [38] The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women.
    Papadimitropoulos, EA
    Goeree, R
    Blackhouse, G
    Coyte, P
    Josse, RG
    Adachi, J
    Greenwood, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S384 - S384
  • [39] Cost-effectiveness of detoxification vs. buprenorphine in pregnancy
    Willey, Alicia S.
    Walker, Allison R.
    Toffey, David E.
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S490 - S490
  • [40] Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Wiwanitkit, Viroj
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (11) : 1675 - 1675
12345